Background/Aims: There are no established guidelines for bowel preparation formulation for bowel cleansing, nor is there an optimal method of dealing with inadequate bowel cleansing. This study investigated bowel preparation formulation preferences and responses to bowel preparation situations using surveys. Methods: The study surveyed 221 Korean lower gastrointestinal endoscopists from January to March 2015 and assessed their responses. Results: The analysis indicated that 2-L polyethylene glycol (PEG) plus ascorbic acid (Asc) was the preferred method (76.5%) and most responders expressed satisfaction with the formulation in both potency and safety. To address poor bowel preparation on the day of colonoscopy, the majority of physicians chose to order ingestion of additional preparations and proceed with the colonoscopy as scheduled (56.6%). In addition, concerns about renal safety and electrolyte stability were raised regarding oral sodium phosphate. Conclusions: This study found that 2-L PEG+Asc was preferred for potency and safety, and that Korean endoscopists preferred to proceed with colonoscopy in poor bowel preparation situations rather than choose an alternate diagnostic modality. (Korean J Gastroenterol 2016;68:70-76) 
INTRODUCTION
Colonoscopy is the most effective screening method for identifying and preventing colorectal cancer, and polypectomy performed with colonoscopy effectively resects precancerous adenomas. 1, 2 Adequate bowel cleansing is essential for accurate colonoscopy and requires an optimal balance of diet control and bowel preparation formulation. An ideal bowel preparation formulation should provide an excellent bowel cleansing effect while preventing electrolyte imbalance, and should also be affordable and well-tolerated by patients. 3 However, no bowel preparation formulation currently available meets all of these criteria, and the choice of bowel preparation formulation largely depends on the patient's condition and the physician's preference and experience with the agents. A 4-L polyethylene glycol (PEG) preparation has minimal influence on serum volume or electrolyte balance, allowing it to be used safely in patients with other comorbidities, such as renal, cardiac, and liver diseases.
not completely finish because of the large volume formulation required (up to 4 L), the bad taste, and the odor, leading to inadequate cleansing. 3, 5 Improving the flavor or fragrance of the formulation has been attempted to address the limitations of PEG and to increase patient compliance. 6 The 2-L PEG plus ascorbic acid (Asc) has a lower required ingestion volume (2 L) and the flavor is more tolerable, increasing compliance and satisfaction while retaining the effectiveness of 4-L PEG. 7 Oral sodium phosphate (OSP) is advantageous because of the small ingestion amount required and overall convenience; some reports have concluded that it is as effective as 2-L PEG＋Asc in bowel cleansing. 8 However, OSP may cause temporary shifts in electrolyte balance, which may lead to complications in patients with a history of fluid-electrolyte balance, heart failure, unstable angina, renal disease, or liver disease with ascites. 9, 10 Additional bowel preparation formulations that are available for patients include magnesium citrate combined with sodium picosulfate, which synergistically stimulates bowel motility for adequate bowel cleansing and also provides improved taste and smell. 11 There are no established guidelines for optimal bowel preparation formulation, bowel cleansing or an optimal method for addressing inadequate bowel cleansing. This study surveyed physicians that were performing colonoscopies in clinical fields to investigate the preferred formulation for bowel preparation, and the solution most commonly related to inadequate bowel preparation. Based on these data, this study discusses optimal bowel cleansing procedures and appropriate response to inadequate bowel preparation.
SUBJECTS AND METHODS

Subjects
This study was based on questionnaires that included 12 
Survey items
The physicians received questionnaires that included 12
questions, for which multiple responses were allowed (Table   1) : the most important factor in choosing bowel preparation formulation and the most preferred formulation of choice, addition of bisacodyl (and if yes, the condition for bisacodyl addition), approach for patients with severe constipation, response to inadequate bowel cleansing on the day of colonoscopy, the most probable cause of inadequate bowel preparation, incidence of electrolyte imbalance due to use of bowel preparation formulations, bowel preparation formulation that most frequently resulted in complications, the most concerning issues regarding prescription of bowel preparation formulas, and the characteristics of various bowel preparation formulations (2-L PEG＋Asc, OSP, and magnesium citrate combined with sodium picosulfate).
Statistics
The subjects were categorized according to their employ- . What is the safety issue of most concern when prescribing bowel preparation formula? were compared between tertiary university hospitals and private clinic/secondary hospitals, but there was no significant difference between the two groups in the majority of the items. A significant difference in the order of frequency was found in only one question: bowel preparation in patients with severe constipation.
The responses from Seoul (and the neighboring area) and other areas were compared, and significant differences were found in the response rates of several items, but there was no difference in the overall trend, and the order of frequency mirrored the other responses.
DISCUSSION
Most physicians chose bowel cleansing potency, rather than safety or compliance, as the most important factor for selecting the bowel preparation formulation. This may be be- cause the degree of bowel cleansing directly influences the completion and complications of colonoscopy. In addition, poor bowel preparation can occur despite good compliance, and the risk of complications from bowel preparation formulation is low. Poor bowel preparation extends the duration of the colonoscopy, increasing patient discomfort and adversely affecting the diagnostic rate of colonic disease. 5 Furthermore, it hinders the cecal insertion rate (greater than 90%), which is an essential component of colonoscopy quality assurance. 12 Among the available bowel preparation formulas, the combination of 2-L PEG＋Asc was preferred compared to other formulas because it required a lower ingestion volume than 4-L PEG, while providing similar bowel cleansing potency 7 and better compliance due to improved flavor.
These advantages were also reflected in the responses to this survey.
In patients with severe constipation, most responders preferred to add laxatives such as bisacodyl or to extend the duration of diet control prior to colonoscopy, rather than dividing the dosage of the bowel preparation formulation. While there are reports that restricting dietary fiber leads to improved bowel preparation, 13 there is insufficient evidence of the association between dietary control and the degree of bowel preparation. Adding bisacodyl to standard dosages of bowel preparation formulation has not been thoroughly investigated and the approach remains controversial. 6 One domestic study reported that the addition of bisacodyl did not result in a significant difference compared to the conventional bowel preparation protocol. 14 This study has several limitations. First, our study is limited in clinical application. This study was designed to investigate the preference on bowel preparation agent and preferred strategies on poor bowel preparation. As it is not an evidence-based study, its results have limited novel value for suggesting clinical application. Second, there is potential bias toward a certain bowel preparation agent since the questionnaire was performed by a private company that markets the agents. While the participants in secondary and tertiary hospitals were directly contacted by the research team once, participants in tertiary hospitals who joined academic meetings were further contacted and asked to respond to preliminary questionnaires to maintain objectiveness. Third, this study compared the differences in colonoscopy practice between tertiary hospitals and private/secondary hospitals.
However, a more detailed sub-analysis could not be done because of private information act policy. Last, this study lacks data on bowel preparation scale such as Boston scale or Otawa scale, resulting in a more subjective analysis of the bowel preparation status. However, this study focused on poorly prepared bowels only, especially the cases that impeded colonoscopy. While a detailed scale was not provided, there would have been little disagreement among endoscopists on the degree of poor bowel preparations of the subjects included in this study.
To our knowledge, this is the first study that conducted a large-scale survey of physicians that prescribe bowel preparation formulations. This investigation allowed us to determine current preferences for bowel preparation and management of poor bowel preparations. While this does not represent the entire population of physicians that perform colonoscopies in South Korea, this study was able to capture current trends in treatment approaches, which is important for establishing guidelines and optimizing outcomes.
